Related Articles
Analysis of clinical risk factors in relapsed patients with class IV lupus nephritis
Expression of IL-23R and IL-17 and the pathology and prognosis of urinary bladder carcinoma
Involvement of TWEAK and the NF-κB signaling pathway in lupus nephritis
Elevated levels of serum IL‑36α in patients with systemic lupus erythematosus
Efficacy and safety of telitacicept in patients with lupus nephritis